-
ISS Says Puma Biotechnology Is In A 'Critical Stage' Of Turnaround Plan, Urges Investors To Vote Against Proposal By Fred Eshelman
Wednesday, December 23, 2015 - 11:45am | 217Read More...Dr. Fred Eshelman is the founder of Eshelman Ventures, an investment firm that focuses on healthcare companies. The investment firm owns approximately 1 percent of Puma Biotechnology Inc (NYSE: PBYI)'s outstanding shares and solicited the company to increase the size of its Board of Directors...
